HSD17B10 and Alzheimer disease: Although there is currently no evidence that the effect of SIRT3 on HSD17B10 can inhibit AD, the inhibition of HSD17B10 activity by amyloid-β (Aβ) can lead to neuronal dysfunction associated with AD (Oppermann et al. 1999; Yan et al. 1997).